Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neuronoff
Cleveland, Ohio, USAneuronoff.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Neuronoff has successfully completed a first-in-human clinical trial (LIFE Study) demonstrating the safety and initial effectiveness of its minimally invasive Injectrode® neuromodulation platform for chronic lower back pain. The company is advancing to further clinical trials in neurogenic and overactive bladder indications with strong federal funding support. The Injectrode enables needle-based placement of an injectable electrode, offering a less invasive alternative to traditional neuromodulation surgery and drug therapies.
- Therapeutic areas
- NeurologyUrology
- Modalities
- DeviceNeuromodulation device (injectable electrode)
- Industry
- Therapeutic Medical Devices
02
Partnerships
University of Texas Health Science Center Houston (clinical trial partner)University of Wisconsin, Massachusetts General Hospital, Case Western Reserve University (preclinical research partners on OAB project)
Beyond the preview
Go deeper on Neuronoff.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Neuronoff.